Impact of COVID-19 on Neuropsychiatric Disorders

Since the Coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), many studies have shown that besides common COVID-19 symptoms, patients may develop various neuropsychiatric conditions including anxiety, mood disorders, psychosis, neurod...

Descripción completa

Detalles Bibliográficos
Autores principales: Zia, Niloufar, Ravanfar, Parsa, Allahdadian, Sepideh, Ghasemi, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456667/
https://www.ncbi.nlm.nih.gov/pubmed/36079143
http://dx.doi.org/10.3390/jcm11175213
_version_ 1784785872567140352
author Zia, Niloufar
Ravanfar, Parsa
Allahdadian, Sepideh
Ghasemi, Mehdi
author_facet Zia, Niloufar
Ravanfar, Parsa
Allahdadian, Sepideh
Ghasemi, Mehdi
author_sort Zia, Niloufar
collection PubMed
description Since the Coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), many studies have shown that besides common COVID-19 symptoms, patients may develop various neuropsychiatric conditions including anxiety, mood disorders, psychosis, neurodegenerative diseases (e.g., dementia), insomnia, and even substance abuse disorders. COVID-19 can also worsen the patients underlying neuropsychiatric and neurodevelopmental conditions during or after the system phase of disease. In this review, we discuss the impact of SARS-CoV-2 infection on development or status of neuropsychiatric conditions during or following COVID-19.
format Online
Article
Text
id pubmed-9456667
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94566672022-09-09 Impact of COVID-19 on Neuropsychiatric Disorders Zia, Niloufar Ravanfar, Parsa Allahdadian, Sepideh Ghasemi, Mehdi J Clin Med Review Since the Coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), many studies have shown that besides common COVID-19 symptoms, patients may develop various neuropsychiatric conditions including anxiety, mood disorders, psychosis, neurodegenerative diseases (e.g., dementia), insomnia, and even substance abuse disorders. COVID-19 can also worsen the patients underlying neuropsychiatric and neurodevelopmental conditions during or after the system phase of disease. In this review, we discuss the impact of SARS-CoV-2 infection on development or status of neuropsychiatric conditions during or following COVID-19. MDPI 2022-09-03 /pmc/articles/PMC9456667/ /pubmed/36079143 http://dx.doi.org/10.3390/jcm11175213 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Zia, Niloufar
Ravanfar, Parsa
Allahdadian, Sepideh
Ghasemi, Mehdi
Impact of COVID-19 on Neuropsychiatric Disorders
title Impact of COVID-19 on Neuropsychiatric Disorders
title_full Impact of COVID-19 on Neuropsychiatric Disorders
title_fullStr Impact of COVID-19 on Neuropsychiatric Disorders
title_full_unstemmed Impact of COVID-19 on Neuropsychiatric Disorders
title_short Impact of COVID-19 on Neuropsychiatric Disorders
title_sort impact of covid-19 on neuropsychiatric disorders
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456667/
https://www.ncbi.nlm.nih.gov/pubmed/36079143
http://dx.doi.org/10.3390/jcm11175213
work_keys_str_mv AT zianiloufar impactofcovid19onneuropsychiatricdisorders
AT ravanfarparsa impactofcovid19onneuropsychiatricdisorders
AT allahdadiansepideh impactofcovid19onneuropsychiatricdisorders
AT ghasemimehdi impactofcovid19onneuropsychiatricdisorders

Ejemplares similares